Lixte Biotechnology Holdings, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
ETHOS FINANCIAL GROUP, LLC | 07/19/2023 | 248,084 | $205,240 | 0.00% | 1.49% |
WELLS FARGO & COMPANY/MN | 08/15/2023 | 0 | $0 | -100.00% | 0.00% |
STATE STREET CORP | 08/14/2023 | 0 | $0 | -100.00% | 0.00% |
VANGUARD GROUP INC | 08/14/2023 | 0 | $0 | -100.00% | 0.00% |
MORGAN STANLEY | 08/14/2023 | 0 | $0 | -100.00% | 0.00% |
TWO SIGMA INVESTMENTS, LP | 08/14/2023 | 0 | $0 | -100.00% | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 08/11/2023 | 0 | $0 | -100.00% | 0.00% |
TOWER RESEARCH CAPITAL LLC (TRC) | 08/14/2023 | 0 | $0 | -100.00% | 0.00% |
EP WEALTH ADVISORS, LLC | 08/14/2023 | 0 | $0 | -100.00% | 0.00% |
NORTHEAST FINANCIAL CONSULTANTS INC | 08/08/2023 | 0 | $0 | -100.00% | 0.00% |
UBS GROUP AG | 08/11/2023 | 0 | $0 | -100.00% | 0.00% |
Lixte Biotechnology Holdings, Inc.institutional Ownership - FAQ's
What percentage of Lixte Biotechnology Holdings, Inc. stock is owned by
institutional investors?
1.49% of Lixte Biotechnology Holdings, Inc. stock is owned by institutional investors.